SEARCH RESULTS FOR: 英戈尔施塔特现在卖B大概多少钱(选妹网站enu28.com真实上门服务)哪家好2023105648379967988324(57813 results)
Only the first 10,000 results were returned. Filter these results or refine your query. Some pre-built queries with more than 10,000 results are available for download.
Mat Silicone for B and B
Avalign Technologies, Inc.
96-4700M
In Commercial Distribution
- 00190776190613 ()
- Instrument tray, reusable
B&B SKIN HOOK; 5''(12.5CM)
BLACK & BLACK SURGICAL, INC.
B61527
In Commercial Distribution
- 00840329806958 ()
B61527
- Soft-tissue surgical hook, reusable
OPERATING SCISSORS CVD B/B 6.5
SKLAR CORPORATION
21-300
In Commercial Distribution
- 40649111036164 ()
- 00649111036166 ()
- General-purpose surgical scissors, reusable
Operating Scissor B/B 5.5"STR
K.T.SURGICO
2025
Not in Commercial Distribution
- SCISSORBB01 ()
- KTS0810214 ()
- TMS1530014 ()
KTS0810214
- General-purpose surgical scissors, single-use
No Description
REMEL EUROPE LIMITED
R30164501
In Commercial Distribution
- 05056080501567 ()
- Multiple meningitis-associated bacteria antigen IVD, reagent
The Revogene® C. difficile assay performed on the Revogene instrument is a qualitative in vitro diagnostic test that utilizes automated sample processing and real-time polymerase chain reaction (PCR) to detect the toxin B (tcdB) gene of toxigenic Clostridium difficile (C. difficile) in unformed (liquid or soft) stool specimens obtained from patients suspected of having C. difficile infection (CDI). The Revogene C. difficile assay is intended to aid in the diagnosis of CDI.
Meridian Bioscience Canada Inc
410300
Not in Commercial Distribution
- 00628055344124 ()
410300
- Clostridium difficile nucleic acid IVD, kit, nucleic acid technique (NAT)
The GenePOC™ CDiff assay performed on the revogene™ instrument is a qualitative in vitro diagnostic test that utilizes automated sample processing and real-time polymerase chain reaction (PCR) to detect the toxin B (tcdB) gene of toxigenic Clostridium difficile (C. difficile) in unformed (liquid or soft) stool specimens obtained from patients suspected of having C. difficile infection (CDI). The GenePOC CDiff assay is intended to aid in the diagnosis of CDI.
GenePoc Inc
132994
Not in Commercial Distribution
- 00628055344025 ()
132994
- Clostridium difficile nucleic acid IVD, kit, nucleic acid technique (NAT)
Rapid Response Respiratory Syncytial Virus Test Cassette - 30 tests/ kit are for the qualitative detection of Respiratory Syncytial Virus Antigen in Nasopharyngeal specimens.
BTNX Inc
RSV-19C30
In Commercial Distribution
- 00722066001974 ()
- 00722066004265 ()
RSV-19C30
- Influenza virus/respiratory syncytial virus (RSV) antigen IVD, kit, immunochromatographic test (ICT), rapid
No Description
QIAGEN GmbH
1
Not in Commercial Distribution
- 04053228004646 ()
4572346
- Clostridium difficile nucleic acid IVD, kit, nucleic acid technique (NAT)
BD MAX™ Cdiff (US)
BECTON, DICKINSON AND COMPANY
443418
In Commercial Distribution
- 00382904434182 ()
443418
- Clostridium difficile nucleic acid IVD, kit, nucleic acid technique (NAT)
The ARIES® C. difficile Assay is a real-time polymerase chain reaction (PCR) based qualitative in vitro diagnostic test for the direct detection of Clostridium difficile (C. difficile) nucleic acid in unformed (liquid or soft) stool specimens obtained from patients suspected of having Clostridium difficile infection (CDI).
LUMINEX CORPORATION
50-10018
Not in Commercial Distribution
- 00840487100059 ()
- Clostridium difficile nucleic acid IVD, kit, nucleic acid technique (NAT)
The Revogene C. difficile assay performed on the Revogene instrument is a qualitative in vitro diagnostic test that utilizes automated sample processing and real time polymerase chain reaction (PCR) to detect the toxin B (tcdB) gene of toxigenic Clostridium difficile in unformed (liquid or soft) stool specimens obtained from patients suspected of having C. difficile infection. The Revogene C. difficile assay is intended to aid in the diagnosis of CDI.
MERIDIAN BIOSCIENCE, INC.
410300
In Commercial Distribution
- 00840733102349 ()
401300
- Clostridium difficile nucleic acid IVD, kit, nucleic acid technique (NAT)
The Alethia™ C. difficile DNA amplification assay, performed on the Alethia™ Instrument, is a qualitative in vitro diagnostic test for the direct detection of toxigenic C. difficile in human stool specimens from pediatric and adult patients suspected of having Clostridium difficile-associated disease (CDAD). The Alethia™ C. difficile assay utilizes loop-mediated isothermal DNA amplification (LAMP) technology to detect the pathogenicity locus (PaLoc) of toxigenic Clostridium difficile. The Clostridium difficile PaLoc is a gene segment present in all known toxigenic C. difficile strains. The C. difficile PaLoc codes for both the Toxin A gene (tcdA) and the Toxin B gene (tcdB), has conserved border regions, and is found at the same site on the C. difficile genome for all toxigenic strains. The Alethia™ C. difficile assay detects the PaLoc by targeting a partial DNA fragment on the Toxin A gene. The tcdA target region was selected as an intact region remaining in all known A+B+ and A-B+ toxinotypes.
MERIDIAN BIOSCIENCE, INC.
480050
In Commercial Distribution
- 00840733102172 ()
480050
- Clostridium difficile nucleic acid IVD, kit, nucleic acid technique (NAT)
The illumigene C. difficile DNA amplification assay, performed on the illumipro-10, is a qualitative in vitro diagnostic test for the direct detection of toxigenic C. difficile in human stool specimens from pediatric and adult patients suspected of having Clostridium difficile-associated disease (CDAD).
The illumigene C. difficile assay utilizes loop-mediated isothermal DNA amplification (LAMP) technology to detect the pathogenicity locus (PaLoc) of toxigenic Clostridium difficile. The Clostridium difficile PaLoc is a gene segment present in all known toxigenic C. difficile strains. The C. difficile PaLoc codes for both the Toxin A gene (tcdA) and the Toxin B gene (tcdB), has conserved border regions, and is found at the same site on the C. difficile genome for all toxigenic strains. The illumigene C. difficile assay detects the PaLoc by targeting a partial DNA fragment on the Toxin A gene. The tcdA target region was selected as an intact region remaining in all known A+B+ and A-B+ toxinotypes.
MERIDIAN BIOSCIENCE, INC.
280050
Not in Commercial Distribution
- 00840733101168 ()
280050
- Clostridium difficile nucleic acid IVD, kit, nucleic acid technique (NAT)
No Description
Vela Operations USA Inc.
00
In Commercial Distribution
- G491CDF2SPD0 ()
CDF2-SPD
- Clostridium difficile nucleic acid IVD, kit, nucleic acid technique (NAT)
No Description
Vela Operations USA Inc.
01
In Commercial Distribution
- G491CDF21 ()
- G491CDF20 ()
300786
- Clostridium difficile nucleic acid IVD, kit, nucleic acid technique (NAT)
No Description
DIASORIN MOLECULAR LLC
MOL5290
In Commercial Distribution
- 20816101025613 ()
MOL5290
- Clostridium difficile nucleic acid IVD, kit, nucleic acid technique (NAT)
No Description
DIASORIN MOLECULAR LLC
MOL2960
In Commercial Distribution
- 20816101025606 ()
MOL2960
- Clostridium difficile nucleic acid IVD, kit, nucleic acid technique (NAT)
No Description
DIASORIN MOLECULAR LLC
MOL2950
In Commercial Distribution
- 20816101025590 ()
MOL2950
- Clostridium difficile nucleic acid IVD, kit, nucleic acid technique (NAT)
No Description
DIASORIN MOLECULAR LLC
MOL2975
In Commercial Distribution
- 20816101025583 ()
MOL2975
- Clostridium difficile nucleic acid IVD, kit, nucleic acid technique (NAT)